Anaphylaxis Emergency Kit for Clinics and Hospitals: A Stocking Checklist
What published guidelines list for an anaphylaxis emergency kit: medicines, equipment, storage, expiry checks and reorder planning for clinics, hospitals and pharmacies in India.
Intra-Articular Hyaluronic Acid for Knee Osteoarthritis in India: What Labels and Guidelines Report
What published guidelines (OARSI, ACR/AF, AAOS, NICE) and product labels report on intra-articular hyaluronic acid for knee osteoarthritis, for hospital and pharmacy buyers in India.
Osimertinib 80 mg in India: Brands, Availability and Sourcing Guide for Hospitals (2026)
Osimertinib has become the reference treatment for EGFR-mutated non-small cell lung cancer (NSCLC), and hospital pharmacies, oncology centres and chemists across India now field the same questions again and again: which osimertinib 80 mg brands are in the market, how do they differ, and how can a buyer confirm that stock is genuine and correctly […]
Multiple Myeloma Treatment in India: What Anti-CD38 Antibody Trial Data and Labels Report
For hospital pharmacy committees, oncology and haematology units, clinics and pharmacies, anti-CD38 monoclonal antibodies are among the most frequently cited biologics in multiple myeloma. This article reports what prescribing information and published trials say about this class, written for institutional buyers and clinicians. It is informational reporting, not clinical guidance. What the Label Describes The […]
Seasonal Influenza Vaccination in India: What Labels and WHO Guidance Report for Hospital Programmes
What manufacturer labels, WHO advisories and Indian bodies report on seasonal quadrivalent influenza vaccines, for hospital and clinic procurement teams.
Neutropenia and G-CSF Therapy in India: What Labels and Guidelines Report
Granulocyte colony-stimulating factors (G-CSFs) such as filgrastim are used in oncology to address neutropenia, a low neutrophil count that raises the risk of serious infection during chemotherapy. Several items bear on how they are discussed: the American Society of Clinical Oncology (ASCO) published an updated guideline on white blood cell growth factors in 2026, the […]
Denosumab 60 mg vs 120 mg: What the Prolia and Xgeva Labels and Trials Report
Denosumab 60 mg vs 120 mg is a comparison hospital pharmacies run into often, because the same medicine is stocked in two very different forms under two different brand names. The 60 mg product (sold as Prolia) and the 120 mg product (sold as Xgeva) contain the same antibody, yet their approved uses, labelled schedules […]
Epinephrine Auto-Injectors in India: What the EpiPen Label and Anaphylaxis Guidance Report
Epinephrine (adrenaline) auto-injectors such as EpiPen and EpiPen Jr are single-dose, pre-filled devices that deliver a fixed dose of epinephrine into the outer thigh. Several recent items bear on how they are discussed: the US prescribing information for EpiPen and EpiPen Jr was revised in March 2026; an international expert panel published consensus recommendations on […]
Fetroja (Cefiderocol) in India: What Published Data Say About This Siderophore Cephalosporin
Cefiderocol, sold as Fetroja, is a cephalosporin antibiotic designed to enter Gram-negative bacteria through their own iron-uptake systems. Three recent developments make it worth a fresh look: the Infectious Diseases Society of America (IDSA) published a new edition of its resistant Gram-negative guidance on 30 July 2026; the US prescribing information for Fetroja was revised […]
2026 Cholesterol Guideline and VESALIUS-CV: What the New Data Say About PCSK9-Pathway Therapy in India
1. Why Cholesterol Guidance Is in the News Again Over the past twelve months, cardiology has produced an unusually dense run of lipid-related publications. A new US dyslipidemia guideline replaced the 2018 cholesterol guideline, a large outcomes trial of a PCSK9 antibody in patients with no prior heart attack or stroke was published, and the […]
